Cardiovascular Drugs and Therapy

eISSN: 1573-7241pISSN: 0920-3206

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
5.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.93

Journal Specifications

Overview
  • Publisher
    SPRINGER
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Aspirin
Myocardial infarction
Heart disease
Atrial fibrillation
Matrix metalloproteinase
Type 2 diabetes
Anticoagulant
Left ventricular hypertrophy
Low-density lipoprotein
Atherosclerotic cardiovascular disease
Heart failure
Warfarin
Percutaneous coronary intervention
Clopidogrel
Naltrexone
Hyperoxia
Coronary heart disease
Confidence interval
Oxidative stress
Clinical trial

Recently Published Papers

Year-wise Publication

FAQs

Since when has Cardiovascular Drugs and Therapy been publishing? Faqs

The Cardiovascular Drugs and Therapy has been publishing since 1987 till date.

How frequently is the Cardiovascular Drugs and Therapy published? Faqs

Cardiovascular Drugs and Therapy is published Bi-monthly.

Who is the publisher of Cardiovascular Drugs and Therapy? Faqs

The publisher of Cardiovascular Drugs and Therapy is SPRINGER.

How can I view the journal metrics of Cardiovascular Drugs and Therapy on editage? Faqs

For the Cardiovascular Drugs and Therapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Cardiovascular Drugs and Therapy? Faqs

The eISSN number is 1573-7241 and pISSN number is 0920-3206 for Cardiovascular Drugs and Therapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Aspirin, Myocardial infarction, Heart disease, Atrial fibrillation, Matrix metalloproteinase, Type 2 diabetes, Anticoagulant, Left ventricular hypertrophy, Low-density lipoprotein, Atherosclerotic cardiovascular disease, Heart failure, Warfarin, Percutaneous coronary intervention, Clopidogrel, Naltrexone, Hyperoxia, Coronary heart disease, Confidence interval, Oxidative stress, Clinical trial.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.